“Our encouraging Phase 2 data for GRANITE in MSS-CRC continue to mature and demonstrate durable benefit over time. With two additional months of follow-up, relative progression-free survival has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback